BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 16342092)

  • 1. Antinuclear antibody titer and antibodies to extractable nuclear antigens.
    Bossuyt X; Hendrickx A; Frans J
    Arthritis Rheum; 2005 Dec; 53(6):987-8. PubMed ID: 16342092
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing.
    Solomon DH; Kavanaugh AJ; Schur PH;
    Arthritis Rheum; 2002 Aug; 47(4):434-44. PubMed ID: 12209492
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines for immunologic laboratory testing in the rheumatic diseases: an introduction.
    American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines
    Arthritis Rheum; 2002 Aug; 47(4):429-33. PubMed ID: 12209491
    [No Abstract]   [Full Text] [Related]  

  • 4. Harmonization of autoimmune diagnostics with antinuclear antibody testing algorithm: approach of appropriateness and clinical relevance.
    Melegari A; Bonaguri C
    Isr Med Assoc J; 2014 Oct; 16(10):640-2. PubMed ID: 25438456
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of antinuclear antibodies in rheumatology].
    Ciobanu V; Boloşiu HD
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(2):97-111. PubMed ID: 2875509
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recent advances in immunologic laboratory testing for rheumatic diseases].
    Akahoshi T
    Rinsho Byori; 2004 Sep; 52(9):743-50. PubMed ID: 15552934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antinuclear antibodies in rheumatology].
    Zuber M
    Z Rheumatol; 1994; 53(6):327-34. PubMed ID: 7871904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to hnRNPs in patients with a systemic rheumatic disease with no antibodies to extractable nuclear antigens or dsDNA.
    De Beéck KO; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
    Rheumatology (Oxford); 2012 Aug; 51(8):1515-6. PubMed ID: 22661555
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnosis of rheumatologic diseases. Significance of autoantibodies against nuclear antigens].
    Poralla T; Mayet W; Hermann E; Manns M; Meyer zum Büschenfelde KH
    Fortschr Med; 1988 Dec; 106(36):726-9. PubMed ID: 3069672
    [No Abstract]   [Full Text] [Related]  

  • 10. Application of a combined protocol for rational request and utilization of antibody assays improves clinical diagnostic efficacy in autoimmune rheumatic disease.
    Tampoia M; Brescia V; Fontana A; Zucano A; Morrone LF; Pansini N
    Arch Pathol Lab Med; 2007 Jan; 131(1):112-6. PubMed ID: 17227110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies.
    Kang I; Siperstein R; Quan T; Breitenstein ML
    Clin Rheumatol; 2004 Dec; 23(6):509-15. PubMed ID: 15801070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
    Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
    J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunologic tests: Anti-mitotic spindle associated antibody].
    Obayashi H; Wada T; Ohta M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():608-10. PubMed ID: 16111346
    [No Abstract]   [Full Text] [Related]  

  • 14. [Difference in the positivity of antinuclear antibodies in pediatrics using rat kidney and human epithelial cells as a source of antigens].
    Arroyave CM; Arroyave ME
    Bol Med Hosp Infant Mex; 1986 Aug; 43(8):478-81. PubMed ID: 3530277
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antibodies against soluble nuclear antigens in rheumatic diseases].
    Nikolov K; Baleva M
    Vutr Boles; 1987; 26(5):112-7. PubMed ID: 3324484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases.
    Bossuyt X; De Langhe E; Borghi MO; Meroni PL
    Nat Rev Rheumatol; 2020 Dec; 16(12):715-726. PubMed ID: 33154583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory tests in rheumatology.
    Caruso I; Caruso EM; Signò P
    J Int Fed Clin Chem; 1994 Sep; 6(4):124-30. PubMed ID: 10155143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laboratory diagnostics in rheumatology].
    Dörner T; Fleck M
    Z Rheumatol; 2016 May; 75(4):354-5. PubMed ID: 27115696
    [No Abstract]   [Full Text] [Related]  

  • 19. [Classification criteria for rheumatic diseases].
    Zeidler H
    Z Rheumatol; 2016 Aug; 75(6):616-9. PubMed ID: 27365025
    [No Abstract]   [Full Text] [Related]  

  • 20. [Standardized outcome parameters].
    Zink A; Albrecht K
    Z Rheumatol; 2016 Aug; 75(6):620-3. PubMed ID: 27379737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.